432 filings
Page 11 of 22
425
5mpu5
21 Sep 18
Business combination disclosure
4:06pm
8-K
rvq6oa713xscjk1fso
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
sobc 5m4w5
21 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
onk1um8 qi
14 Aug 18
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
7:35am
8-K
vmrv0ua
13 Aug 18
Departure of Directors or Certain Officers
4:05pm
8-K
aqrn mm1b5sii4lq3hu
9 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
qdbwwv 40csdk
18 Jul 18
Cancer Genetics Closes $2.625 million Convertible Note Financing
4:18pm
8-K
kvfg9p3t
5 Jul 18
Entry into a Material Definitive Agreement
4:59pm
8-K
cj9b q2rt
27 Jun 18
Entry into a Material Definitive Agreement
4:05pm
8-K
tly3hz cv
13 Jun 18
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
12:00am
8-K
6zv9 emud5
15 May 18
Provides Strategic Business Updates
7:05am
8-K
951xhy3
1 May 18
Departure of Directors or Certain Officers
8:45am
8-K
a8j2n
27 Apr 18
Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated
9:26am
8-K
ettircirb53k 7whpo
2 Apr 18
Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates
12:00am
8-K
69tpn
5 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
izi4dfsg 5p
28 Dec 17
Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
12:00am